Go here to read the rest:
Celon Pharma Announces Positive Falkieri Phase II Results in Treatment-Resistant Bipolar Depression
Category Archives: Global News Feed
Leading BioSciences Announces Positive Topline Data from Open-Label Gastrointestinal Surgery Study
Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™
Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day
Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in…
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering
Read the original post:
LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering
Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001
Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020
Osmotica Pharmaceuticals plc to Present at 2020 Jefferies Virtual London Healthcare Conference
Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer
Go here to see the original:
Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer
Eyenovia to Report Third Quarter 2020 Results on Tuesday, November 10
Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting
Go here to read the rest:
Immutep’s TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual Meeting
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020
Innovation Pharmaceuticals and George Mason University Announce Public Release of Laboratory Testing Results Demonstrating Brilacidin’s COVID-19…
AzurRx BioPharma Announces Formation of Scientific Advisory Board
electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business…
The Quest for Blockbuster Drugs Continues
Continued here:
The Quest for Blockbuster Drugs Continues